CRWM
IONS icon

Castle Rock Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Castle Rock Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,122
Closed -$215K – 259
2025
Q2 		$215K Buy
+5,122
New +$168K 0.05% 238
2025
Q1 		– Sell
-6,972
Closed -$216K – 230
2024
Q4 		$216K Hold
6,972
– – 0.05% 223
2024
Q3 		$264K Hold
6,972
– – 0.06% 216
2024
Q2 		$328K Hold
6,972
– – 0.08% 188
2024
Q1 		$300K Hold
6,972
– – 0.08% 189
2023
Q4 		$352K Hold
6,972
– – 0.11% 168
2023
Q3 		$327K Sell
6,972
-400
-5% -$16.5K 0.11% 162
2023
Q2 		$311K Sell
7,372
-12,013
-62% -$462K 0.11% 166
2023
Q1 		$692K Hold
19,385
– – 0.25% 94
2022
Q4 		$763K Sell
19,385
-500
-3% -$21K 0.34% 85
2022
Q3 		$906K Buy
19,885
+4,292
+28% +$181K 0.46% 51
2022
Q2 		$573K Hold
15,593
– – 0.29% 97
2022
Q1 		$639K Hold
15,593
– – 0.29% 100
2021
Q4 		$466K Hold
15,593
– – 0.19% 144
2021
Q3 		$544K Hold
15,593
– – 0.19% 147
2021
Q2 		$606K Hold
15,593
– – 0.22% 128
2021
Q1 		$662K Buy
15,593
+730
+5% +$40.7K 0.27% 130
2020
Q4 		$918K Buy
+14,863
New +$741K 0.38% 85
2020
Q3 		– Sell
-15,263
Closed -$904K – 190
2020
Q2 		$904K Buy
15,263
+400
+3% +$22.3K 0.53% 58
2020
Q1 		$778K Hold
14,863
– – 0.67% 32
2019
Q4 		$896K Hold
14,863
– – 0.81% 37
2019
Q3 		$842K Buy
+14,863
New +$969K 0.87% 29
2019
Q2 		– Sell
-14,863
Closed -$1K – 153
2019
Q1 		$1K Buy
+14,863
New +$959K 0.04% 24

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Castle Rock Wealth Management's IONS Position: Q3 2025 in Review

Castle Rock Wealth Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2025, closing a stake of 5,122 shares — an estimated $215K sold.

Castle Rock Wealth Management first reported a position in IONS in Q1 2019 and held it in 23 quarters. The position peaked at $918K in Q4 2020. 436 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Castle Rock Wealth Management reported no remaining Ionis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Castle Rock Wealth Management sold 5,122 Ionis Pharmaceuticals shares in Q3 2025, an estimated $215K.
  • Castle Rock Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 23 quarters.
  • Castle Rock Wealth Management's Ionis Pharmaceuticals position peaked at $918K in Q4 2020.
  • 436 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Castle Rock Wealth Management's 13F filing for Q3 2025, filed 16 Oct 2025.